propranolol has been researched along with Toxoplasmosis, Animal in 3 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Toxoplasmosis, Animal: Acquired infection of non-human animals by organisms of the genus TOXOPLASMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Khorshidvand, Z | 1 |
| Shirian, S | 1 |
| Amiri, H | 1 |
| Zamani, A | 1 |
| Maghsood, AH | 1 |
| Benedetto, N | 2 |
| Folgore, A | 2 |
| Galdiero, M | 2 |
| Ferrara, C | 1 |
3 other studies available for propranolol and Toxoplasmosis, Animal
| Article | Year |
|---|---|
Immunomodulatory chitosan nanoparticles for Toxoplasma gondii infection: Novel application of chitosan in complex propranolol-hydrochloride as an adjuvant in vaccine delivery.
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Animals; Antigens, Protozoan; Chitosan; Cytokines; | 2023 |
Impairment of natural resistance to Toxoplasma gondii infection in rats treated with beta adrenergics, beta blockers, corticosteroids or total body irradiation.
Topics: Animals; Antigens, Surface; Betamethasone; Epinephrine; Immunity, Innate; Propranolol; Rats; Rats, I | 1993 |
Susceptibility to toxoplasmosis: correlation between macrophage function, brain cyst formation and mortality in rats.
Topics: Adrenergic beta-Antagonists; Animals; Betamethasone; Brain Diseases; Cysts; Disease Susceptibility; | 1996 |